Avanos Medical Inc (AVNS)

Debt-to-capital ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 828,500 1,229,700 1,222,000 1,227,900 1,236,300 1,222,100 1,234,800 1,298,700 1,291,200 1,263,500 1,251,600 1,256,500 1,263,900 1,261,900 1,296,300 1,252,600 1,256,500 1,289,900 1,261,600 1,256,500
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $828,500K)
= 0.00

The debt-to-capital ratio of Avanos Medical Inc has been consistently reported as 0.00 across all quarters from March 31, 2020, to December 31, 2024. This indicates that the company has not used any debt to finance its operations or investments during this period. A debt-to-capital ratio of 0.00 means that the company's capital structure is entirely composed of equity and there is no debt in the financial structure. This could imply that Avanos Medical Inc has been relying solely on equity financing, which can be a positive sign as it reduces the financial risk associated with debt obligations.